Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/14/23
End: 02/29/24
Due: 02/28/25
Phase: N/A
Priority: Normal
Start: 02/28/23
End: 09/30/24
Due: 09/30/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| EASE (Efficacy of ATX01 Study in Erythromelalgia) | NCT05917912 | AlgoTherapeutix | user2@example.com | None | 2023-06-14 | 2024-02-29 | 2025-02-28 | - | - | 2025-07-14 |
| Efficacy and Safety of ATX01 in Adult Patients With CIPN (Chemotherapy-induced Peripheral Neuropathy) | NCT05593614 | AlgoTherapeutix | user2@example.com | None | 2023-02-28 | 2024-09-30 | 2025-09-30 | - | - | 2025-07-14 |